Shares of Walgreens Boots Alliance dropped more than 15% Friday morning, after the pharmacy chain suspended quarterly dividends, citing the need for cash amid litigation and turnaround efforts. The Ju
Walgreens is suspending its quarterly dividend as the company works to “evaluate and refine its capital allocation policy" amid its turnaround efforts.
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.
U.S.-based pharmacy chain Walgreens Boots Alliance (WBA) suspended its long-standing dividend to preserve cash and prioritize its turnaround
Walgreens suspends its quarterly dividend for the first time in 92 years as it faces challenges in its financial turnaround effort.
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In fact, according to reporting from Bloomberg and The Financial Times in 2019, big private equity firm KKR made a $70 billion offer that year. However, KKR denied putting in a binding bid.
Walgreens Boots Alliance's prospective sale to a private equity firm is " mostly dead ," sources told CNBC's David Faber, according to a Jan. 27 report from The Wall Street Journal. Here are five things to know: 1. In December, the Journal reported that Walgreens could sell itself to private equity firm Sycamore Partners and become private in 2025.
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is
U.S. stocks rose after more companies said they made bigger profits at the end of last year than analysts expected and as Treasury yields eased.
Truist lowered the firm’s price target on Walgreens Boots Alliance (WBA) to $12 from $13 and keeps a Hold rating on the shares. The firm is
Wall Street pointed higher early Friday as more strong earnings results trickled in along with a closely-watched report from the U.S. government showing that inflation ticked higher. Futures for the S&P 500 rose 0.